Citation: M. Engelhard et M. Stuschke, 3. Report on Workshop: UICC Workshop "Therapy of NHL in early stages" - Part 1: Follicular lymphoma, ANN HEMATOL, 80, 2001, pp. B13-B15
Authors:
Brandt-Mainz, K
von Mallek, D
Pottgen, C
Eising, EG
Bockisch, A
Stuschke, M
Sack, H
Citation: K. Brandt-mainz et al., Parametric oesophageal multiple swallow scintigraphy for validation of dysphageal symptoms during external beam irradiation of mediastinal tumours, EUR J NUCL, 28(3), 2001, pp. 313-319
Authors:
Fischer, M
Stuben, G
Klahold, M
Stuschke, M
Budach, V
Sack, H
Jahnke, K
Citation: M. Fischer et al., Accelerated hyperfractionated radiotherapy with concurrent chemotherapy inlocally advanced nasopharyngeal carcinoma: a phase II study, J CANC RES, 127(8), 2001, pp. 507-511
Authors:
Stuben, G
Thews, O
Pottgen, C
Knuhmann, K
Vaupel, P
Stuschke, M
Citation: G. Stuben et al., Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice, J CANC RES, 127(6), 2001, pp. 346-350
Citation: A. Sak et al., Protection of DNA from radiation-induced double-strand breaks: influence of replication and nuclear proteins, INT J RAD B, 76(6), 2000, pp. 749-756
Authors:
Stuschke, M
Stahl, M
Wilke, H
Walz, M
Oldenburg, A
Stuben, G
Seeber, S
Sack, H
Citation: M. Stuschke et al., Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus, AM J CL ONC, 23(3), 2000, pp. 233-238
Citation: M. Stuschke et al., Evidence for an influence of overall treatment time on radiotherapeutic - Outcome in different tumor entities, STRAH ONKOL, 176(10), 2000, pp. 462-465
Authors:
Beinert, T
Binder, D
Oehm, C
Ziemer, S
Priem, E
Stuschke, M
Schweigert, M
Siebert, G
Mergenthaler, HG
Schmid, P
Fleischhacker, M
Possinger, K
Citation: T. Beinert et al., Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy, J CANC RES, 126(6), 2000, pp. 352-356
Authors:
Stuschke, M
Eberhardt, W
Pottgen, C
Stamatis, G
Wilke, H
Stuben, G
Stoblen, F
Wilhelm, HH
Menker, H
Teschler, H
Muller, RD
Budach, V
Seeber, S
Sack, H
Citation: M. Stuschke et al., Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigationsof late neuropsychologic effects, J CL ONCOL, 17(9), 1999, pp. 2700-2709
Authors:
Stuben, G
Thews, O
Pottgen, C
Stuschke, M
Sack, H
Citation: G. Stuben et al., Tumour oxygenation during fractionated radiotherapy - Comparison with size-matched controls, ACTA ONCOL, 38(2), 1999, pp. 209-213
Citation: M. Stuschke, Accelerated hyperfractionated compared with conventional radiotherapy in limited small-cell lung cancer with concurrent chemotherapy, STRAH ONKOL, 175(6), 1999, pp. 296-298
Citation: M. Stuschke et Hd. Thames, Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials, RADIOTH ONC, 51(2), 1999, pp. 113-121
Authors:
Stuschke, M
Stahl, M
Wilke, H
Walz, MK
Oldenburg, AR
Stuben, G
Jahnke, K
Seeber, S
Sack, H
Citation: M. Stuschke et al., Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus, ONCOL-BASEL, 57(2), 1999, pp. 99-105
Authors:
Eberhardt, W
Stamatis, G
Stuschke, M
Wilke, H
Muller, MR
Kolks, S
Flasshove, M
Schutte, J
Stahl, M
Schlenger, L
Budach, V
Greschuchna, D
Stuben, G
Teschler, H
Sack, H
Seeber, S
Citation: W. Eberhardt et al., Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial, BR J CANC, 81(7), 1999, pp. 1206-1212